UC Davis exceeded $1 billion in external research funding in the fiscal year 2022–23. The School of Medicine contributed 40% of this amount, achieving a new research funding record.
Read MoreUC Davis and Orgenesis are rolling out processing units that allow cell and gene therapies to be developed and manufactured onsite. This will increase patient access to therapies.
Read MoreChair of Physical Medicine and Rehabilitation Craig McDonald was honored with a 2023 Top Ten Clinical Research Achievement Award, in recognition of his remarkable work on Duchenne muscular dystrophy.
Read MoreResearchers have begun a new stem cell clinical trial to treat patients with swallowing problems. The study takes stem cells and injects them into the patient’s tongue.
Read MoreProfessor Aijun Wang won a $2 million grant from California’s Stem Cell Agency to develop a cure to Duchenne muscular dystrophy (DMD) using an in-utero gene editing formula.
Read MoreImmunologist William Murphy discusses CAR T-cell cancer therapy and his work with Caring Cross, CIRM and UC Davis researchers to find novel cures to leukemia and lymphoma.
Read MoreCIRM awarded UC Davis’ Alpha Stem Cell Clinic an $8 million grant renewal to expand its successful clinical trials operation and advance toward onsite manufacturing of therapies.
Read MoreMichelle and Jeff were excited to build their new family together, but when she received the distressing news that her developing baby was diagnosed with spina bifida, she looked for the best treatment. She was referred to the CuRe trial.
Read MoreThree babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
Read MoreCardiothoracic surgery resident Nataliya Bahatyrevich has become the latest UC Davis trainee to receive a prestigious T32 federal research grant. The award will allow her to spend a year in the laboratory and pursue a Master of Science in biomedical engineering at UC Davis
Read MoreStem cell researcher Jan Nolta received the Lifetime Achievement Award in Innovation during the 2022 Chancellor’s Innovation Awards ceremony on June 16. The awards recognize faculty, community partners and industry leaders developing innovative solutions to improve the lives of others and address important needs in the global society.
Read MoreProfessor Aijun Wang won $3 million grant from California Institute for Regenerative Medicine to develop a smart durable vascular device for hemodialysis patients treated for kidney failure. The device uses a unique molecule to help prevent synthetic vascular graft failure, a common problem for patients undergoing hemodialysis.
Read MoreThe UC Davis MIND Institute is launching a $4 million research program aimed at finding transformative therapies for ADNP syndrome, a rare genetic condition. A group of interdisciplinary researchers will evaluate multiple gene therapies for possible use.
Read MoreIn a first of its kind clinical trial led by UC Davis Health, HOPE-2 showed that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
Read MoreUC Davis Health researchers showed that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease, an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation.
Read MoreUC President Michael Drake was at the UC Davis Health campus to help induct the new presidential chair in vitreoretinal science. The inaugural appointment of world-renowned physician Paul A. Sieving was held Sept. 17 with recognition of Neil and MJ Kelly and their generous donation that established the Kelly Presidential Chair in Vitreoretinal Science.
Read MoreProfessors David Segal and Deborah Lieu have received Discovery Stage Research Projects awards from the California Institute for Regenerative Medicine (CIRM). The grants will fund cell gene therapy for Angelman syndrome and building the first biopacemaker
Read MoreA groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body’s antiviral immunity, and restore the gut’s lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies.
Read MoreA UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.
Read MoreCalifornia’s stem cell agency awarded funding to UC Davis Health researchers for the first human clinical trial using stem cells to treat spina bifida.
Read More